CAR-NKT cell therapy eliminates aggressive endometrial tumors in mice

UCLA researchers developed a novel CAR-NKT cell therapy showing promise against aggressive endometrial cancer. The therapy uses engineered immune cells to target mesothelin, a protein found on cancer cells, and has demonstrated complete tumor elimination in mouse models. This off-the-shelf therapy is designed to be more accessible and affordable than current personalized immunotherapies and could potentially treat multiple cancer types.